Loading…
Synthesis of Feruloyl- myo-insitol derivatives and their inhibitory effects on phorbol ester-induced superoxide generation and esptein–barr virus activation
We prepared 14 feruloyl- myo-inositol derivatives, and evaluated the relationships between their stereostructure and inhibitory activity toward the 12- O-tetradecanoylphorbol-13-acetate (TPA)-induced superoxide (O 2 −) generation. And further, their suppressive effect on the TPA-induced Epstein–Barr...
Saved in:
Published in: | Bioorganic & medicinal chemistry 2002-06, Vol.10 (6), p.1855-1863 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | We prepared 14 feruloyl-
myo-inositol derivatives, and evaluated the relationships between their stereostructure and inhibitory activity toward the 12-
O-tetradecanoylphorbol-13-acetate (TPA)-induced superoxide (O
2
−) generation. And further, their suppressive effect on the TPA-induced Epstein–Barr virus (EBV) activation was examined in order to estimate their anti-carcinogenic potentials. Among the derivatives tested, 1,6-
O-bis[3-(4′-hydroxy-3′-methoxyphenyl)-2-propenoyl]-
myo-inositol (
6b) showed an excellent suppressive activity on the O
2
− generation at a concentration of 20
μM. For the suppressive effects on the EBV activation, 2,4,6-
O-tris[3-(4′-hydroxy-3′-methoxyphenyl)-2-propenoyl]-
myo-inositol 1,3,5-orthoformate (
9b) showed the highest activity at a concentration of 100
μM among the derivatives tested. These results suggest that the inhibitory potencies of feruloyl-
myo-inositol derivatives depend on the stereostructure of molecules rather than the hydrophobicity of molecules.
We prepared 14 feruloyl-
myo-inositol derivatives, and examined their structure–activity relationship of the inhibitory activity toward the TPA-induced O
2
− generation and the EBV activation. |
---|---|
ISSN: | 0968-0896 1464-3391 |
DOI: | 10.1016/S0968-0896(02)00010-X |